ErlySign Bags INR 16 Cr To Develop Cancer Diagnostic Solutions

ErlySign Bags INR 16 Cr To Develop Cancer Diagnostic Solutions

SUMMARY

The fresh proceeds will be deployed in clinical trials, securing CDSCO (Central Drugs Standard Control Organisation) approvals, and bringing ErlySign’s oral cancer detection kit to market

Founded in 2019 by Shubhendra Singh Thakur and Deovrat Begde, ErlySign develops solutions for early detection of oral cancer

The company also claims to offer India’s first salivary biomarker based test which can identify pre- cancerous conditions

Healthtech startup ErlySign has secured INR 16 Cr (around $1.8 Mn) in Pre-Series A funding round from Ashish Kacholia to further develop its cancer diagnostic solutions. 

The fresh proceeds will be deployed in clinical trials, securing CDSCO (Central Drugs Standard Control Organisation) approvals, and bringing ErlySign’s oral cancer detection kit to market, the startup said in its statement. 

Note: We at Inc42 take our ethics very seriously. More information about it can be found here.

No results were found for "".
  • «
  • 1
  • »
modal lock

Continue Reading With A Free Inc42 Account

Get the most out of your Inc42 experience by creating a free account. Enjoy personalized recommendations, ad-lite browsing, and access to our exclusive newsletters.